NuCana plc
28Patents
28Active
28Granted
51Portfolio score
Filing activity: Jun 25, 2015 → Sep 22, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| USRE47589E1 | Phosphoramidate compounds and methods of use | General | 32 | Active |
| US10117888B2 | Formulation comprising a gemcitabine-prodrug | Human Necessities | 18 | Active |
| US10022390B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 13 | Active |
| US10786523B2 | Formulation comprising a gemcitabine-prodrug | Human Necessities | 7 | Active |
| US10993957B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US10570168B2 | 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti- cancer compounds | Chemistry; Metallurgy | 4 | Active |
| US11040051B2 | Formulation comprising a gemcitabine-prodrug | Human Necessities | 3 | Active |
| US10662213B2 | Gemcitabine prodrugs | Human Necessities | 3 | Active |
| US10660912B2 | Combination therapy for cancer | Human Necessities | 3 | Active |
| US11559542B2 | Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 2 | Active |
| US10906929B2 | Phosphoramidate nucleoside derivatives as anticancer agents | Chemistry; Metallurgy | 2 | Active |
| US10669300B2 | Methods of separating gemcitabine-phosphate diastereoisomers | Chemistry; Metallurgy | 2 | Active |
| US11414451B2 | Floxuridine synthesis | Chemistry; Metallurgy | 1 | Active |
| US11400107B2 | Cancer treatments | Chemistry; Metallurgy | 1 | Active |
| US11414452B2 | Synthesis of phosphate derivatives | Emerging Cross-Sectional Technologies | 1 | Active |
| US11352387B2 | 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds | Chemistry; Metallurgy | 1 | Active |
| US11560400B2 | Salts of diphosphate phosphoramidate of nucleosides as anticancer compounds | Chemistry; Metallurgy | 0 | Active |
| US11897913B2 | Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]phosphate (NUC-738) | Emerging Cross-Sectional Technologies | 0 | Active |
| US11925658B2 | Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US11786544B2 | Formulations of phosphoramidate derivatives of nucleoside drugs | Human Necessities | 0 | Active |
| US11377467B2 | Crystalline form of gemcitabine | Chemistry; Metallurgy | 0 | Active |
| US11040997B2 | Process for preparing nucleoside prodrugs | Electricity | 0 | Active |
| US12054510B2 | 2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine derivatives as anti-cancer compounds | Chemistry; Metallurgy | 0 | Active |
| US11603382B2 | Diastereoselective synthesis of phosphate derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US11629164B2 | Gemcitabine prodrugs | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.